DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Gilead Sciences Inc. $(GILD)$ advanced 2.46% to $111.11 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.40% to 5,912.17 and the Dow Jones Industrial Average rising 0.28% to 42,215.73.
Gilead Sciences Inc. closed 7.38% below its 52-week high of $119.96, which the company reached on March 10th.
The stock outperformed some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ rose 0.75% to $153.58, Pfizer Inc. $(PFE)$ rose 1.16% to $23.45, and Abbott Laboratories $(ABT)$ rose 0.63% to $132.85.
Trading volume (5.6 M) remained 4.0 million below its 50-day average volume of 9.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 29, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 29, 2025 16:36 ET (20:36 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。